The Hidden Dangers of Fentanyl in Stimulants: What You Need to Know
Episode Overview
Mail-in drug testing programs allow submission of drug specimens for analysis Regional variability in drug supply affects fentanyl contamination rates Average number of substances found in drug samples is 1.7, posing significant risks Powdered drugs are more prone to adulteration than crystal or rock forms Education and naloxone provision are vital for mitigating opioid overdose risk in stimulant users
For our patients with stimulant use disorder who do not use opioids, we need to inform them of the risk of exposure to opioids and opioid overdose when they use stimulants and provide them with naloxone.
Ever wondered what’s really in the drugs circulating on the streets? Dr. Casey Grover tackles this alarming issue head-on in this episode of 'Addiction in Emergency Medicine and Acute Care'. The spotlight is on a troubling trend: stimulants like meth and cocaine laced with fentanyl. Dr. Grover dives into a revealing study that tested various samples of these stimulants, uncovering just how widespread fentanyl contamination has become. Spoiler: it's alarmingly common.
Through a mix of hard data and practical advice, Dr. Grover breaks down the risks this poses to those using stimulants. You'll hear about the regional differences in drug supply, which can make the situation even more unpredictable. Plus, he highlights the crucial role of drug checking services in preventing accidental overdoses. These services can be a literal lifesaver, helping users identify dangerous contaminants before it's too late. But it’s not just about stats and studies. Dr.
Grover emphasizes the human side of the issue, urging healthcare professionals to educate and protect their patients from unintended fentanyl exposure. If you’re involved in emergency medicine or just concerned about the growing drug crisis, this episode offers essential insights and practical strategies to tackle one of the most pressing problems in addiction treatment today.